| |
|
| |
|
|
|
|
|
3rd Annual PharmaLytica 2012 brings you a revised and refreshed agenda focussing on the current and extremely critical analytical challenges that were never covered before |
|
|
|
| This year, PharmaLytica India 2012 is structured into separately bookable modules revolving around techniques to deal with issues relating to regulatory lab compliance , GLP , PAT, particle size characterisation and morphology , polymorphism , analytical method development , validation and transfer and rapid microbiological techniques . |
| |
NEW FOR 2012 - Attend this unique conference to get to grips with the most critical challenges faced by the analytical domain including:
- Strategies to overcome OOS and OOT situations
- Latest developments in data integrity and data management techniques – 21 CFR Part 11
- CAPA – Failure investigation techniques and quality risk management
- Effective Implementation strategies for PAT with respect to QbD
- Advances in dissolution testing
- Reverse enginering charaterisation of formulations
|
| |
| Who should attend? |
| |
This conference has been designed specifically for VPs, Directors, Heads and senior designations of
- Analytical laboratories
- Analytical developments
- Analytical services
- Analytical R&D
- Formulation
- Quality control
- Quality assurance
- Regulatory affairs
- Pharmacovigilance
- R&D
- Sourcing/procurement
- Technical services
- Business development
- Sales & marketing
- Market development
From: Generic Pharma Manufacturers, Biopharma Manufacturers, Innovative Pharma Manufacturers, CRAMS, Analytical laboratories, IT vendors, Instrumentation Suppliers, Chemical and media suppliers, Biotechnology companies |
| |
|
|
|
|
|
|
| |
|
|
|
 |
|
|
